Bamfords Pharmacy Limited

Bamfords Pharmacy Limited
Contents Page
For the year ended 31 March 2026

Accountants' Report	1
Statement of Financial Position	2
Notes to the Financial Statements	3

Bamfords Pharmacy Limited Accountants' Report For the year ended 31 March 2026
Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts Bamfords Pharmacy Limited for the year ended 31 March 2026 In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Bamfords Pharmacy Limited for the year ended 31 March 2026 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Chartered Institute of Management Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.cimaglobal.com. This report is made solely to the Board of Directors of Bamfords Pharmacy Limited , as a body, in accordance with the terms of our engagement letter dated 19 June 2026. Our work has been undertaken solely to prepare for your approval the accounts of Bamfords Pharmacy Limited and state those matters that we have agreed to state to the Board of Directors of Bamfords Pharmacy Limited, as a body, in this report in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Bamfords Pharmacy Limited and its Board of Directors as a body for our work or for this report It is your duty to ensure that Bamfords Pharmacy Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit Bamfords Pharmacy Limited. You consider that Bamfords Pharmacy Limited is exempt from the statutory audit requirement for the year We have not been instructed to carry out an audit or a review of the accounts of Bamfords Pharmacy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts. .................................................... Rivington Accounts Ltd Bank House 6-8 Church Street Adlington Lancashire PR7 4EX 19 June 2026 1

Bamfords Pharmacy Limited
Accountants' Report
For the year ended 31 March 2026

Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts Bamfords Pharmacy Limited for the year ended 31 March 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Bamfords Pharmacy Limited for the year ended 31 March 2026 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Chartered Institute of Management Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.cimaglobal.com.
This report is made solely to the Board of Directors of Bamfords Pharmacy Limited , as a body, in accordance with the terms of our engagement letter dated 19 June 2026. Our work has been undertaken solely to prepare for your approval the accounts of Bamfords Pharmacy Limited and state those matters that we have agreed to state to the Board of Directors of Bamfords Pharmacy Limited, as a body, in this report in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Bamfords Pharmacy Limited and its Board of Directors as a body for our work or for this report
It is your duty to ensure that Bamfords Pharmacy Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit Bamfords Pharmacy Limited. You consider that Bamfords Pharmacy Limited is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of Bamfords Pharmacy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

....................................................
Rivington Accounts Ltd
Bank House
6-8 Church Street
Adlington
Lancashire
PR7 4EX
19 June 2026

1

Bamfords Pharmacy Limited
Statement of Financial Position
As at 31 March 2026

	Notes	2026 £	2025 £
Fixed assets
Tangible fixed assets	4	15,731	20,077
		15,731	20,077
Current assets
Stocks		34,906	34,315
Debtors		33,706	29,491
Cash at bank and in hand		240,934	170,336
		309,546	234,142
Creditors: amount falling due within one year		(123,625)	(72,760)
Net current assets		185,921	161,382

Total assets less current liabilities		201,652	181,459
Provisions for liabilities		(4,158)	(5,217)
Net assets		197,494	176,242

Capital and reserves
Called up share capital	5	104	104
Profit and loss account		197,390	176,138
Shareholders' funds		197,494	176,242

For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the board of directors on 19 June 2026 and were signed on its behalf by:

-------------------------------
Martin Bamford
Director

2

Bamfords Pharmacy Limited
Notes to the Abridged Financial Statements
For the year ended 31 March 2026

General Information

Bamfords Pharmacy Limited is a private company, limited by shares, registered in England and Wales, registration number 06276379, registration address Bank House, 6-8 Church Street, Adlington, Lancashire, PR7 4EX.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Deferred taxation

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.

Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Motor Vehicles	25% Reducing Balance
Fixtures and Fittings	20% Reducing Balance
Computer Equipment	3 Years Straight Line
Improvements to property	50 Years Straight Line

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

Provisions

Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.

2.	Average number of employees Average number of employees during the year was 6 (2025 : 6).

3.

Intangible fixed assets

Cost	Goodwill	Total
	£	£
At 01 April 2025	798,283	798,283
Additions	-	-
Disposals	-	-
At 31 March 2026	798,283	798,283
Amortisation
At 01 April 2025	798,283	798,283
Charge for year	-	-
On disposals	-	-
At 31 March 2026	798,283	798,283
Net book values
At 31 March 2026	-	-
At 31 March 2025	-	-

4.

Tangible fixed assets

Cost or valuation	Motor Vehicles	Fixtures and Fittings	Computer Equipment	Improvements to property	Total
	£	£	£	£	£
At 01 April 2025	29,235	35,345	81,585	2,040	148,205
Additions	-	-	419	-	419
Disposals	-	-	-	-	-
At 31 March 2026	29,235	35,345	82,004	2,040	148,624
Depreciation
At 01 April 2025	15,178	31,995	80,785	170	128,128
Charge for year	3,514	670	540	41	4,765
On disposals	-	-	-	-	-
At 31 March 2026	18,692	32,665	81,325	211	132,893
Net book values
Closing balance as at 31 March 2026	10,543	2,680	679	1,829	15,731
Opening balance as at 01 April 2025	14,057	3,350	800	1,870	20,077

5.

Share Capital

Allotted, called up and fully paid	2026 £	2025 £
100 Ordinary shares of £1.00 each	100	100
4 Ordinary A shares of £1.00 each	4	4
	104	104

3


Registered Number: 06276379
England and Wales
BAMFORDS PHARMACY LIMITED

Abridged Accounts

Period of accounts Start date: 01 April 2025 End date: 31 March 2026